Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nils Morten Leknes
Institution:
University Hospital of North Norway
Observed institutions:
University Hospital of North Norway,
Sørlandet Sykehus
ORCID:
0009-0006-1011-138X
Observed ORCID:
0009-0006-1011-138X
OpenAlex ID:
A5120587342
Optimizing lenalidomide therapy in renal impairment: analysis of renal response in the prospective REMNANT study in transplant-eligible newly diagnosed multiple myeloma
2025
·
Frida Bugge Askeland
, Vilhelm Hauge Bugge
, et al.
·
Blood Cancer Journal
·
2
PDF
MRD-Negative Response After VRd induction, HD-ASCT, and VRd consolidation in Transplant-Eligible Newly Diagnosed Multiple Myeloma: Phase 2 REMNANT Study with Broad Inclusion Criteria
2026
·
Frida Bugge Askeland
, Anne-Marie Rasmussen
, et al.
·
Research Square
PDF
Rettelse: Når Nye metoder er i utakt med klinisk praksis, må ikke livreddende behandling hindres
2026
·
Nils Morten Leknes
, Anders Vik
, et al.
·
Tidsskrift for Den norske legeforening
PDF
Optimizing lenalidomide therapy in renal impairment: Analysis of renal response in the prospective remnant study in transplant-eligible newly diagnosed multiple myeloma
2025
·
Frida Bugge Askeland
, Vilhelm Hauge Bugge
, et al.
·
Blood
PDF
Når Nye metoder er i utakt med klinisk praksis, må ikke livreddende behandling hindres
2025
·
Nils Morten Leknes
, Anders Vik
, et al.
·
Tidsskrift for Den norske legeforening
PDF
Show more works
View as search
Works count:
5
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type